# Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.

Study · id `cardio:ct-nct04046029` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04046029](<https://clinicaltrials.gov/study/NCT04046029>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04046029

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.

## Technical summary

Registry record NCT04046029. Randomized; single masking; primary purpose treatment. Start 2019-07-08 (actual); primary completion 2020-07-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 240 participants (planned count; ClinicalTrials.gov record NCT04046029, source copy `cardio:ctgov-nct04046029-2019-08-06`, retrieved 2026-10-31)
- Started: 2019-07-08 (actual) (ClinicalTrials.gov record NCT04046029, source copy `cardio:ctgov-nct04046029-2019-08-06`, retrieved 2026-10-31)
- Primary completion: 2020-07-30 (anticipated) (ClinicalTrials.gov record NCT04046029, source copy `cardio:ctgov-nct04046029-2019-08-06`, retrieved 2026-10-31)
- Completion: 2021-06-30 (anticipated) (ClinicalTrials.gov record NCT04046029, source copy `cardio:ctgov-nct04046029-2019-08-06`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT04046029, source copy `cardio:ctgov-nct04046029-2019-08-06`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04046029-2019-08-06`, retrieved 2026-10-31)

## The registry's words

- Brief title: Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.
- Condition: Acute Coronary Syndrome
- Condition: Percutaneous Coronary Intervention
- Condition: Aging
- Condition: Anticoagulants and Bleeding Disorders
- Intervention (Drug): Bivalirudin
- Intervention (Drug): Heparin
- Lead sponsor: The First Affiliated Hospital of Dalian Medical University
- Lead sponsor class: OTHER
- Collaborator: Beijing Friendship Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry intervention name matches this record: Bivalirudin (`cardio:bivalirudin`)
- Registry intervention name matches this record: Heparin (`cardio:heparin`)
- Registry intervention is a member of this class by a sourced record link: Anticoagulants (`cardio:anticoagulants`)
- Registry lists this organization as the lead sponsor: The First Affiliated Hospital of Dalian Medical University (`cardio:org-the-first-affiliated-hospital-of-dalian-medical-university`)
- Registry lists this organization as a collaborator: Beijing Friendship Hospital (`cardio:org-beijing-friendship-hospital`)

## Provenance

Content hash: 8b6fd3558939c668048c06deabade403d0aa945fae80a371f6b6f77b4f4ebc4f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
